FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2608872586> ?p ?o ?g. }

• W2608872586 endingPage "322" @default.
• W2608872586 startingPage "314" @default.
• W2608872586 abstract "The study aims to explore the relationship between expressions of HER2 and JAK/STAT3-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer (OC).A total of 136 OC patients were collected. Immunohistochemistry was applied to measure the expressions of STAT3, p-STAT3, SOCS3, HER2 and p-HER2 in the tumor tissues and adjacent normal tissues. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the mRNA expressions of HER2, SOCS3 and STAT3 and western blotting was applied for protein expressions of HER2, p-HER2, SOCS3, STAT3 and p-STAT3 in the tumor tissues and adjacent normal tissues. Flow cytometry was used for the cell apoptosis in the blank, afatinib (A), ruxolitinib (R) and afatinib + ruxolitinib (A + R) groups. Follow-up was performed to explore relationship of HER2, SOCS3, and STAT3 expressions with survival time of OC patients.HER2, p-HER2, STAT3, and p-STAT3 expressions were higher while SOCS3 expression was lower in the tumor tissues. The positive expressions of STAT3, HER2, p-HER2 and p-STAT3 were lower while the positive expression of SOCS3 was higher in the adjacent normal tissues. The expressions of HER2, SOCS3, and p-STAT3 were associated with clinical stage and lymph node metastasis (LNM), and STAT3 expression has correlation with histological grade and LNM. The mRNA and protein expressions of HER2, STAT3 and p-STAT3 in the tumor tissues were higher than those in the adjacent normal tissues, but SOCS3 expression was significantly decreased. The positive expressions of HER2, p-HER2 and STAT3, the negative expression of SOCS3 and pathological stages were important risk factors for the prognosis of patients with OC.Our study showed that the expressions of HER2, STAT3, and SOCS3 are associated with the progression of OC, and higher expressions of HER2 and STAT3 and lower expression of SOCS3 predict poor prognosis of OC." @default.
• W2608872586 created "2017-05-05" @default.
• W2608872586 creator A5010607811 @default.
• W2608872586 creator A5014271490 @default.
• W2608872586 creator A5024134085 @default.
• W2608872586 creator A5032907494 @default.
• W2608872586 creator A5033269841 @default.
• W2608872586 creator A5053384619 @default.
• W2608872586 creator A5053936942 @default.
• W2608872586 creator A5056329233 @default.
• W2608872586 creator A5058555426 @default.
• W2608872586 creator A5091180355 @default.
• W2608872586 date "2017-04-27" @default.
• W2608872586 modified "2023-10-17" @default.
• W2608872586 title "Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer" @default.
• W2608872586 cites W1843430922 @default.
• W2608872586 cites W1968638668 @default.
• W2608872586 cites W1974646913 @default.
• W2608872586 cites W1980295206 @default.
• W2608872586 cites W1980494624 @default.
• W2608872586 cites W1991582255 @default.
• W2608872586 cites W1994727820 @default.
• W2608872586 cites W1999506362 @default.
• W2608872586 cites W2005069110 @default.
• W2608872586 cites W2008697072 @default.
• W2608872586 cites W2016921045 @default.
• W2608872586 cites W2022549763 @default.
• W2608872586 cites W2029944582 @default.
• W2608872586 cites W2053665867 @default.
• W2608872586 cites W2060370509 @default.
• W2608872586 cites W2061284491 @default.
• W2608872586 cites W2089889294 @default.
• W2608872586 cites W2102092354 @default.
• W2608872586 cites W2102912734 @default.
• W2608872586 cites W2106767659 @default.
• W2608872586 cites W2109032096 @default.
• W2608872586 cites W2110790636 @default.
• W2608872586 cites W2113089439 @default.
• W2608872586 cites W2113122060 @default.
• W2608872586 cites W2120284003 @default.
• W2608872586 cites W2126594066 @default.
• W2608872586 cites W2129313403 @default.
• W2608872586 cites W2132526578 @default.
• W2608872586 cites W2154759247 @default.
• W2608872586 cites W2160466424 @default.
• W2608872586 cites W2171283491 @default.
• W2608872586 cites W2183345893 @default.
• W2608872586 cites W2409165199 @default.
• W2608872586 cites W2435381879 @default.
• W2608872586 doi "https://doi.org/10.1080/15384047.2017.1310343" @default.
• W2608872586 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5499756" @default.
• W2608872586 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28448787" @default.
• W2608872586 hasPublicationYear "2017" @default.
• W2608872586 type Work @default.
• W2608872586 sameAs 2608872586 @default.
• W2608872586 citedByCount "41" @default.
• W2608872586 countsByYear W26088725862017 @default.
• W2608872586 countsByYear W26088725862018 @default.
• W2608872586 countsByYear W26088725862019 @default.
• W2608872586 countsByYear W26088725862020 @default.
• W2608872586 countsByYear W26088725862021 @default.
• W2608872586 countsByYear W26088725862022 @default.
• W2608872586 countsByYear W26088725862023 @default.
• W2608872586 crossrefType "journal-article" @default.
• W2608872586 hasAuthorship W2608872586A5010607811 @default.
• W2608872586 hasAuthorship W2608872586A5014271490 @default.
• W2608872586 hasAuthorship W2608872586A5024134085 @default.
• W2608872586 hasAuthorship W2608872586A5032907494 @default.
• W2608872586 hasAuthorship W2608872586A5033269841 @default.
• W2608872586 hasAuthorship W2608872586A5053384619 @default.
• W2608872586 hasAuthorship W2608872586A5053936942 @default.
• W2608872586 hasAuthorship W2608872586A5056329233 @default.
• W2608872586 hasAuthorship W2608872586A5058555426 @default.
• W2608872586 hasAuthorship W2608872586A5091180355 @default.
• W2608872586 hasBestOaLocation W26088725861 @default.
• W2608872586 hasConcept C121608353 @default.
• W2608872586 hasConcept C126042315 @default.
• W2608872586 hasConcept C126322002 @default.
• W2608872586 hasConcept C204232928 @default.
• W2608872586 hasConcept C2778923194 @default.
• W2608872586 hasConcept C2780427987 @default.
• W2608872586 hasConcept C502942594 @default.
• W2608872586 hasConcept C62478195 @default.
• W2608872586 hasConcept C71924100 @default.
• W2608872586 hasConcept C86803240 @default.
• W2608872586 hasConcept C95444343 @default.
• W2608872586 hasConceptScore W2608872586C121608353 @default.
• W2608872586 hasConceptScore W2608872586C126042315 @default.
• W2608872586 hasConceptScore W2608872586C126322002 @default.
• W2608872586 hasConceptScore W2608872586C204232928 @default.
• W2608872586 hasConceptScore W2608872586C2778923194 @default.
• W2608872586 hasConceptScore W2608872586C2780427987 @default.
• W2608872586 hasConceptScore W2608872586C502942594 @default.
• W2608872586 hasConceptScore W2608872586C62478195 @default.
• W2608872586 hasConceptScore W2608872586C71924100 @default.
• W2608872586 hasConceptScore W2608872586C86803240 @default.
• W2608872586 hasConceptScore W2608872586C95444343 @default.
• W2608872586 hasIssue "5" @default.

• next